Long Island Jewish Medical Center

Summary

Long Island Jewish Medical Center is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Breast Cancer, Chronic Lymphocytic Leukemia, Ovarian Cancer, Lymphoma and other specialties. Long Island Jewish Medical Center is involved with conducting 229 clinical trials across 377 conditions. There are 23 research doctors associated with this hospital, such as Veena John, MD, Craig E. Devoe, Marina Frimer, MD, and Joanna Rhodes, MD.

Top PIs

Clinical Trials running at Long Island Jewish Medical Center

Oral Cancers

Ovarian Cancer

Oral Squamous Cell Carcinoma

Laryngeal Cancer

Pancreatic Cancer

Lip and Oral Cavity Cancer

Oropharyngeal Carcinoma

Multiple Myeloma

Childhood Obesity

Endometrial Cancer

Sentinel Lymph Node Biopsy vs Neck Dissection

for Oral Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.

Recruiting

1 award

Phase 2 & 3

Radiation Therapy + Cisplatin

for Head and Neck Cancer

This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.

Recruiting

1 award

Phase 2

19 criteria